ArticleNature communications2020

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.

Xuping Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.